These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 14707072)

  • 1. Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.
    Kusmartsev S; Nefedova Y; Yoder D; Gabrilovich DI
    J Immunol; 2004 Jan; 172(2):989-99. PubMed ID: 14707072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells.
    Gabrilovich DI; Velders MP; Sotomayor EM; Kast WM
    J Immunol; 2001 May; 166(9):5398-406. PubMed ID: 11313376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species.
    Kusmartsev S; Gabrilovich DI
    J Leukoc Biol; 2003 Aug; 74(2):186-96. PubMed ID: 12885935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of splenic Gr-1int immature myeloid cells in tumor-bearing mice.
    Yamamoto Y; Ishigaki H; Ishida H; Itoh Y; Noda Y; Ogasawara K
    Microbiol Immunol; 2008 Jan; 52(1):47-53. PubMed ID: 18352913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of immature myeloid progenitors with nitric-oxide-dependent immunosuppressive activity isolated from bone marrow of tumor-free mice.
    Forghani P; Harris W; Giver CR; Mirshafiey A; Galipeau J; Waller EK
    PLoS One; 2013; 8(7):e64837. PubMed ID: 23843936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells.
    Kusmartsev S; Nagaraj S; Gabrilovich DI
    J Immunol; 2005 Oct; 175(7):4583-92. PubMed ID: 16177103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive oxygen species and 12/15-lipoxygenase contribute to the antiproliferative capacity of alternatively activated myeloid cells elicited during helminth infection.
    Brys L; Beschin A; Raes G; Ghassabeh GH; Noël W; Brandt J; Brombacher F; De Baetselier P
    J Immunol; 2005 May; 174(10):6095-104. PubMed ID: 15879104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer.
    Schmidt K; Zilio S; Schmollinger JC; Bronte V; Blankenstein T; Willimsky G
    Blood; 2013 Mar; 121(10):1740-8. PubMed ID: 23305737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential differentiation of tumor bearing mouse CD11b+Gr-1+ immature myeloid cells into both suppressor macrophages and immunostimulatory dendritic cells.
    Narita Y; Wakita D; Ohkur T; Chamoto K; Nishimura T
    Biomed Res; 2009 Feb; 30(1):7-15. PubMed ID: 19265258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.
    Dobrzanski MJ; Reome JB; Dutton RW
    J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen presentation by an immature myeloid dendritic cell line does not cause CTL deletion in vivo, but generates CD8+ central memory-like T cells that can be rescued for full effector function.
    Dumortier H; van Mierlo GJ; Egan D; van Ewijk W; Toes RE; Offringa R; Melief CJ
    J Immunol; 2005 Jul; 175(2):855-63. PubMed ID: 16002683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial potential and reactive oxygen intermediates in antigen-specific CD8+ T cells during viral infection.
    Grayson JM; Laniewski NG; Lanier JG; Ahmed R
    J Immunol; 2003 May; 170(9):4745-51. PubMed ID: 12707355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells.
    Hosoi A; Matsushita H; Shimizu K; Fujii S; Ueha S; Abe J; Kurachi M; Maekawa R; Matsushima K; Kakimi K
    Int J Cancer; 2014 Apr; 134(8):1810-22. PubMed ID: 24150772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination.
    Kusmartsev S; Cheng F; Yu B; Nefedova Y; Sotomayor E; Lush R; Gabrilovich D
    Cancer Res; 2003 Aug; 63(15):4441-9. PubMed ID: 12907617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice.
    Bronte V; Serafini P; De Santo C; Marigo I; Tosello V; Mazzoni A; Segal DM; Staib C; Lowel M; Sutter G; Colombo MP; Zanovello P
    J Immunol; 2003 Jan; 170(1):270-8. PubMed ID: 12496409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis.
    Zhu B; Bando Y; Xiao S; Yang K; Anderson AC; Kuchroo VK; Khoury SJ
    J Immunol; 2007 Oct; 179(8):5228-37. PubMed ID: 17911608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating the expression of IFN regulatory factor 8 alters the protumorigenic behavior of CD11b+Gr-1+ myeloid cells.
    Stewart TJ; Liewehr DJ; Steinberg SM; Greeneltch KM; Abrams SI
    J Immunol; 2009 Jul; 183(1):117-28. PubMed ID: 19542426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of oncofetal antigen/immature laminin receptor protein epitopes that activate BALB/c mouse OFA/iLRP-specific effector and regulatory T cell clones.
    Rohrer JW; Barsoum AL; Coggin JH
    J Immunol; 2006 Mar; 176(5):2844-56. PubMed ID: 16493041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-induced CD11b(+) Gr-1(+) myeloid-derived suppressor cells exacerbate immune-mediated hepatitis in mice in a CD40-dependent manner.
    Kapanadze T; Medina-Echeverz J; Gamrekelashvili J; Weiss JM; Wiltrout RH; Kapoor V; Hawk N; Terabe M; Berzofsky JA; Manns MP; Wang E; Marincola FM; Korangy F; Greten TF
    Eur J Immunol; 2015 Apr; 45(4):1148-58. PubMed ID: 25616156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophages are more potent immune suppressors ex vivo than immature myeloid-derived suppressor cells induced by metastatic murine mammary carcinomas.
    Hamilton MJ; Bosiljcic M; Lepard NE; Halvorsen EC; Ho VW; Banáth JP; Krystal G; Bennewith KL
    J Immunol; 2014 Jan; 192(1):512-22. PubMed ID: 24285836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.